FIELD: immunology. SUBSTANCE: the first component of complement is removed from serum blood by addition of polyethylene glycol (molecular mass is 6 kDa) at concentration 4.1-4.3%. After precipitate removing supernatant is diluted by two-fold with 4.1-4.3% of the same polyethylene glycol aqueous solution and acidified to pH = 5.5. All residual activity of C1 is transferred to precipitate. Then precipitate is removed by centrifugation and the obtained reagent is alkalinized to pH = 6.5. EFFECT: improved method of reagent preparing. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING HEMOLYTIC ACTIVITY OF THE THIRD COMPONENT OF HUMAN BLOOD SERUM COMPLEMENT | 0 |
|
SU1649434A1 |
ARTIFICIAL HEART VENTRICLE | 1996 |
|
RU2115439C1 |
AXIAL VANE PUMP FOR AUXILIARY BLOOD CIRCULATION | 1993 |
|
RU2131271C1 |
IMMUNOMODULATING DRUG | 1988 |
|
RU2027434C1 |
ARTIFICIAL VENTRICLE OF HEAT | 1997 |
|
RU2140793C1 |
IMPLANTED VENTRICLE OF THE HEART | 1999 |
|
RU2180858C2 |
METHOD FOR DONOR SELECTION IN ALLOTRANSPLANTATION OF THE KIDNEY | 0 |
|
SU1725124A1 |
METHOD OF EXPRESS-DIAGNOSIS OF CONGENITAL INFECTIONS IN CHILDREN | 1995 |
|
RU2089910C1 |
PEPTIDES SHOWING IMMUNOSTIMULATING ACTIVITY, METHOD OF THEIR SYNTHESIS, DRUG BASED ON THEREOF, SPLENOPID AND ITS USING | 1998 |
|
RU2152219C1 |
METHOD FOR DETERMINING INTEGRAL FUNCTIONAL ACTIVITY OF HUMAN COMPLEMENT COMPONENT C1 | 2013 |
|
RU2542399C1 |
Authors
Dates
1997-06-27—Published
1993-09-15—Filed